How changes in metabolism and the epigenome affect sleep patterns in Alzheimer's disease

The epigenome-metabolism nexus as a driver of circadian disruption in Alzheimer's disease

NIH-funded research Purdue University · NIH-11163912

This study is looking at how changes in sleep patterns and metabolism might be linked to Alzheimer's disease, using fruit flies to help understand the connections and find new ways to help treat the condition.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionPurdue University NIH-funded
Lab location1 site (West Lafayette, United States)
Project IDNIH-11163912 on NIH RePORTER

What this research studies

This research investigates the relationship between circadian rhythms, metabolism, and Alzheimer's disease. It explores how disruptions in sleep patterns may not only be symptoms of Alzheimer's but could also play a role in its development. Using fruit fly models, the study aims to identify the underlying mechanisms that connect metabolic changes to circadian disruptions. By examining the molecular processes involved, the research seeks to uncover potential targets for therapeutic intervention.

Who could benefit from this research

Good fit: Ideal candidates for this research are adults over 21 years old who are experiencing symptoms of Alzheimer's disease or related dementias.

Not a fit: Patients who are under 21 years old or do not have any form of Alzheimer's disease or related dementia may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for managing sleep disturbances in Alzheimer's patients, potentially slowing disease progression.

How similar studies have performed: Previous research has shown promising results in understanding the connection between circadian rhythms and neurodegenerative diseases, suggesting that this approach could yield valuable insights.

Where this research is happening

West Lafayette, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.